Third International Conference on Arsenic Exposure and Health Effects, July 12-15, 1998, San Diego, California. Syracuse NY: The Society for Environmental Geochemistry and Health, 1998 Jul; :38
Link
NIOSHTIC No.
20030403
Abstract
Although more experimental data are now available on the mechanisms of adverse effects of As in animal and human cell lines, little is known about the chemical and metabolic conversion that arsenicals undergo in cultured cells. The present work provides preliminary data on the metabolism of inorganic As (iAs) in selected cell lines, including human epidermal keratinocytes, HeLa (human cervical epithelioid carcinoma), rat primary hepatocytes and human primary hepatocytes. Among the cell lines examined, rat primary hepatocytes exhibited the greatest capacity for methylation of iAs. At nanomolar concentrations of iAs, these cells produced almost exclusively dimethyl As (DMAs); a small amount of methyl As (MAs) was detected in these cells. Yields of methylated metabolites increased with addition of up to 1 um iAs; however, the DMAs/MAs ratio was decreased. Production of MAs and DMAs was significantly suppressed in presence of 10 uM iAs and was almost abolished at 100 uM iAs. This suggested that the biomethylation of As was inhibited in a concentration-dependent manner. Methylation of iAs in HeLa cells yielded mostly MAs that was retained in cells. Addition of thiols stimulated efflux of MAs into the medium, suggesting that transport of this metabolite across the membrane could be thiol-dependent. Only a trace amount of MAs, but no DMAs, was detected in human keratinocytes that were incubated with iAs for 24 hours. Human primary hepatocytes isolated from tissue that was stored in preservation medium for 24 hours before perfusion were poor methylators of iAs. Here, MAs was the predominant metabolite. Taken together, the results indicate that there are important differences between cell lines in the capacity for methylation of iAs. Some of these differences may be species specific.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.